HK1000551A1 - Ocular tension depressant - Google Patents

Ocular tension depressant Download PDF

Info

Publication number
HK1000551A1
HK1000551A1 HK97102015A HK97102015A HK1000551A1 HK 1000551 A1 HK1000551 A1 HK 1000551A1 HK 97102015 A HK97102015 A HK 97102015A HK 97102015 A HK97102015 A HK 97102015A HK 1000551 A1 HK1000551 A1 HK 1000551A1
Authority
HK
Hong Kong
Prior art keywords
group
compound
formula
alkyl group
salt
Prior art date
Application number
HK97102015A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1000551B (en
Inventor
Yokoyama Tomihisa
Yanagisawa Hiroaki
Hosokawa Tsunemichi
Original Assignee
Sankyo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Limited filed Critical Sankyo Company Limited
Priority to HK01105807.1A priority Critical patent/HK1035485B/en
Publication of HK1000551B publication Critical patent/HK1000551B/en
Publication of HK1000551A1 publication Critical patent/HK1000551A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK97102015A 1994-03-16 1997-10-23 Ocular tension depressant HK1000551A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK01105807.1A HK1035485B (en) 1994-03-16 1997-10-23 Ocular tension lowering agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP45404/94 1994-03-16
JP4540494 1994-03-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK01105807.1A Division HK1035485B (en) 1994-03-16 1997-10-23 Ocular tension lowering agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK01105807.1A Addition HK1035485B (en) 1994-03-16 1997-10-23 Ocular tension lowering agent

Publications (2)

Publication Number Publication Date
HK1000551B HK1000551B (en) 2002-04-12
HK1000551A1 true HK1000551A1 (en) 2002-04-12

Family

ID=12718322

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102015A HK1000551A1 (en) 1994-03-16 1997-10-23 Ocular tension depressant

Country Status (20)

Country Link
US (1) US5925664A (enExample)
EP (2) EP0795326B1 (enExample)
KR (1) KR100211446B1 (enExample)
CN (2) CN1104898C (enExample)
AT (2) ATE266402T1 (enExample)
AU (1) AU684916B2 (enExample)
CZ (1) CZ284395B6 (enExample)
DE (2) DE69533045T2 (enExample)
DK (2) DK0795326T3 (enExample)
ES (2) ES2221872T3 (enExample)
FI (2) FI114897B (enExample)
GR (1) GR3036989T3 (enExample)
HK (1) HK1000551A1 (enExample)
HU (1) HUT74734A (enExample)
MX (1) MX9604109A (enExample)
NO (1) NO311068B1 (enExample)
NZ (1) NZ282485A (enExample)
PT (2) PT1110551E (enExample)
RU (1) RU2123847C1 (enExample)
WO (1) WO1995024902A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201466A3 (en) * 1999-06-11 2003-04-28 Sankyo Co Ocular tension lowering composition for topical administration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
WO2002045748A1 (en) * 2000-12-05 2002-06-13 Sankyo Company, Limited Ocular tension-lowering compositions for topical administration
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
ZA875052B (en) * 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
AU644802B2 (en) * 1989-06-30 1993-12-23 E.I. Du Pont De Nemours And Company Substituted imidazoles
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
WO1995021609A1 (en) * 1994-02-08 1995-08-17 Ciba-Geigy Ag Treatment of normotensive glaucoma with angiotensin ii antagonists

Also Published As

Publication number Publication date
CZ269496A3 (en) 1996-12-11
GR3036989T3 (en) 2002-01-31
HU9602534D0 (en) 1996-11-28
DE69522955T2 (de) 2002-05-29
RU2123847C1 (ru) 1998-12-27
AU684916B2 (en) 1998-01-08
KR100211446B1 (ko) 1999-08-02
DK0795326T3 (da) 2001-11-26
NO963854D0 (no) 1996-09-13
NZ282485A (en) 1997-06-24
ES2163501T3 (es) 2002-02-01
FI20041236L (fi) 2004-09-24
EP1110551B1 (en) 2004-05-12
ATE266402T1 (de) 2004-05-15
DE69533045D1 (de) 2004-06-17
HUT74734A (en) 1997-02-28
NO311068B1 (no) 2001-10-08
KR970701542A (ko) 1997-04-12
DK1110551T3 (da) 2004-06-07
FI114897B (fi) 2005-01-31
FI963645A7 (fi) 1996-11-14
PT795326E (pt) 2002-01-30
DE69533045T2 (de) 2005-01-27
CN1104898C (zh) 2003-04-09
EP1110551A3 (en) 2001-08-16
AU1960295A (en) 1995-10-03
FI963645A0 (fi) 1996-09-16
US5925664A (en) 1999-07-20
EP1110551A2 (en) 2001-06-27
MX9604109A (es) 1997-09-30
EP0795326A1 (en) 1997-09-17
CZ284395B6 (cs) 1998-11-11
CN1148809A (zh) 1997-04-30
WO1995024902A1 (en) 1995-09-21
ATE206050T1 (de) 2001-10-15
EP0795326B1 (en) 2001-09-26
EP0795326A4 (enExample) 1997-09-17
CN1202819C (zh) 2005-05-25
ES2221872T3 (es) 2005-01-16
FI115197B (fi) 2005-03-31
DE69522955D1 (de) 2001-10-31
PT1110551E (pt) 2004-07-30
CN1387846A (zh) 2003-01-01
NO963854L (no) 1996-11-14

Similar Documents

Publication Publication Date Title
US20080221184A1 (en) Combined agents for treatment of glaucoma
EP0795326B1 (en) Ocular tension depressant
HK1000551B (en) Ocular tension depressant
CA2185524C (en) Ocular tension depressant
EP1186302B1 (en) Ocular tension lowering composition for topical adminstration
JP2826077B2 (ja) 眼圧低下剤
HK1035485A1 (en) Ocular tension lowering agent
HK1035485B (en) Ocular tension lowering agent
JP4132798B2 (ja) 局所投与のための眼圧低下組成物
JP3790093B2 (ja) 局所投与用眼圧低下組成物
HK1042050B (en) Ocular tension lowering composition for topical adminstration
HK1055894A (en) Combined angiotensin ii antagonists and carbonic anhydrase inhibitors for treatment of glaucoma
HK1055684A (en) Combined angiotensin ii antagonists and adrenaline receptor blockers for treatment of glaucoma

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100316